JP Stock MarketDetailed Quotes

D. Western Therapeutics Institute (4576)

Watchlist

90
-1-1.10%

20min DelayTrading May 7 13:49 JST

5.13BMarket Cap-6.82P/E (Static)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

D. Western Therapeutics Institute (4576) Income Statement

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2025

(Q1)Mar 31, 2025

(FY)Dec 31, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

Total revenue

-17.80%387.62M

-7.69%96.76M

10.09%471.58M

21.49%118.7M

16.47%104.82M

-4.40%428.36M

-17.69%114.37M

27.40%126.28M

-2.60%97.71M

-17.97%90M

Cost of revenue

-17.04%38.86M

10.64%10.1M

27.76%46.84M

27.67%9.4M

24.51%9.13M

33.01%36.67M

4.42%8.94M

121.59%13.03M

20.24%7.37M

4.71%7.33M

Gross profit

-17.89%348.76M

-9.44%86.66M

8.43%424.74M

20.98%109.3M

15.75%95.69M

-6.86%391.7M

-19.14%105.43M

21.46%113.25M

-4.08%90.35M

-19.52%82.67M

Operating expense

-40.73%968.63M

-44.83%228.66M

37.31%1.63B

-2.93%240.35M

125.57%414.49M

63.85%1.19B

141.57%446.35M

47.15%312.54M

31.31%247.61M

30.59%183.75M

Research and development costs

-51.03%669.78M

-58.91%142.51M

46.99%1.37B

-3.88%174.54M

206.48%346.86M

98.16%930.51M

225.92%384.89M

65.36%250.86M

46.67%181.58M

48.97%113.18M

Other operating expenses

12.11%298.86M

27.40%86.15M

2.62%266.57M

-0.34%65.81M

-4.19%67.62M

1.12%259.75M

-7.83%61.46M

1.62%61.68M

1.95%66.04M

9.03%70.58M

Operating profit

48.75%-619.87M

55.46%-142M

-51.47%-1.21B

16.67%-131.05M

-215.37%-318.8M

-161.04%-798.56M

-526.81%-340.92M

-67.25%-199.29M

-66.64%-157.27M

-166.08%-101.09M

Net non-operating interest income (expenses)

-8.68%-17.7M

-67.40%-1.45M

-320.23%-16.29M

-954.20%-9.92M

32.68%-865K

73.87%-3.88M

57.10%-674K

85.92%-976K

82.76%-941K

-47.19%-1.29M

Non-operating interest income

2,615.79%2.06M

11,275.00%455K

660.00%76K

--0

-33.33%4K

-60.00%10K

--0

-66.67%4K

--0

-53.85%6K

Non-operating interest expense

69.19%8.82M

118.99%1.9M

109.24%5.21M

106.01%1.23M

38.82%869K

-20.88%2.49M

-1.17%674K

-21.72%591K

-27.31%599K

-29.35%626K

Total other finance cost

-1.83%10.95M

----

699.00%11.15M

----

-88.08%1.4M

--0

-93.72%389K

--342K

--665K

Net investment income

384.00%7.92M

-264.91%-4.36M

-75.61%1.64M

-39.16%3.09M

120.23%2.65M

-79.83%6.71M

84.79%-681K

-77.33%1.12M

-75.88%5.07M

-89.81%1.2M

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

87.05%-12.99M

Income from associates and other participating interests

Special income (charges)

831K

-247.41%-60.61M

60.47%-17.45M

Less:Other special charges

----

--60.61M

----

Less:Write off

----

---831K

--0

----

--17.45M

----

Other non-operating income (expenses)

78.07%-844K

18.94%-2.79M

-499.38%-3.85M

-661.60%-952K

-2,035.40%-3.44M

92.30%-642K

-103.46%-140K

-58.82%-216K

99.05%-125K

-116.50%-161K

Income before tax

51.08%-630.49M

53.26%-149.77M

-55.87%-1.29B

-30.14%-199.45M

-216.25%-320.45M

-87.80%-826.8M

-85.63%-372.86M

-64.37%-199.36M

-66.56%-153.26M

-288.13%-101.33M

Income tax

0.00%1.6M

0.00%398K

0.00%1.6M

0.00%399K

0.00%398K

0.00%1.6M

0.00%399K

0.00%398K

Net income

51.01%-632.09M

53.20%-150.17M

-55.76%-1.29B

-30.06%-199.84M

-215.40%-320.85M

-87.48%-828.4M

-85.46%-373.25M

-64.16%-199.76M

-66.27%-153.66M

-283.80%-101.73M

Net income continuous operations

51.01%-632.09M

53.20%-150.17M

-55.76%-1.29B

-30.06%-199.85M

-215.40%-320.85M

-87.48%-828.4M

-85.46%-373.26M

-64.16%-199.76M

-66.28%-153.66M

-283.81%-101.73M

Noncontrolling interests

-31.29%-15.99M

-342.94%-4.76M

33.01%-3.82M

6.75%-3.54M

16.73%-3.87M

Net income attributable to the company

51.01%-632.09M

53.20%-150.17M

-58.82%-1.29B

-33.12%-199.84M

-227.87%-320.85M

-89.07%-812.41M

-81.33%-368.49M

-68.93%-195.94M

-69.40%-150.12M

-347.65%-97.86M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

51.01%-632.09M

53.20%-150.17M

-58.82%-1.29B

-33.12%-199.84M

-227.87%-320.85M

-89.07%-812.41M

-81.33%-368.49M

-68.93%-195.94M

-69.40%-150.12M

-347.65%-97.86M

Gross dividend payment

Basic earnings per share

64.10%-13.19

65.87%-3.41

-43.74%-36.74

-29.68%-6.16

-218.15%-9.99

-76.28%-25.56

-69.71%-11.54

-55.58%-6.13

-57.28%-4.75

-324.32%-3.14

Diluted earnings per share

64.10%-13.19

65.87%-3.41

-43.74%-36.74

-29.68%-6.16

-218.15%-9.99

-76.28%-25.56

-69.71%-11.54

-55.58%-6.13

-57.28%-4.75

-324.32%-3.14

Dividend per share

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(FY)Dec 31, 2025	(Q1)Mar 31, 2025	(FY)Dec 31, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023
Total revenue	-17.80%387.62M	-7.69%96.76M	10.09%471.58M	21.49%118.7M	16.47%104.82M	-4.40%428.36M	-17.69%114.37M	27.40%126.28M	-2.60%97.71M	-17.97%90M
Cost of revenue	-17.04%38.86M	10.64%10.1M	27.76%46.84M	27.67%9.4M	24.51%9.13M	33.01%36.67M	4.42%8.94M	121.59%13.03M	20.24%7.37M	4.71%7.33M
Gross profit	-17.89%348.76M	-9.44%86.66M	8.43%424.74M	20.98%109.3M	15.75%95.69M	-6.86%391.7M	-19.14%105.43M	21.46%113.25M	-4.08%90.35M	-19.52%82.67M
Operating expense	-40.73%968.63M	-44.83%228.66M	37.31%1.63B	-2.93%240.35M	125.57%414.49M	63.85%1.19B	141.57%446.35M	47.15%312.54M	31.31%247.61M	30.59%183.75M
Research and development costs	-51.03%669.78M	-58.91%142.51M	46.99%1.37B	-3.88%174.54M	206.48%346.86M	98.16%930.51M	225.92%384.89M	65.36%250.86M	46.67%181.58M	48.97%113.18M
Other operating expenses	12.11%298.86M	27.40%86.15M	2.62%266.57M	-0.34%65.81M	-4.19%67.62M	1.12%259.75M	-7.83%61.46M	1.62%61.68M	1.95%66.04M	9.03%70.58M
Operating profit	48.75%-619.87M	55.46%-142M	-51.47%-1.21B	16.67%-131.05M	-215.37%-318.8M	-161.04%-798.56M	-526.81%-340.92M	-67.25%-199.29M	-66.64%-157.27M	-166.08%-101.09M
Net non-operating interest income (expenses)	-8.68%-17.7M	-67.40%-1.45M	-320.23%-16.29M	-954.20%-9.92M	32.68%-865K	73.87%-3.88M	57.10%-674K	85.92%-976K	82.76%-941K	-47.19%-1.29M
Non-operating interest income	2,615.79%2.06M	11,275.00%455K	660.00%76K	--0	-33.33%4K	-60.00%10K	--0	-66.67%4K	--0	-53.85%6K
Non-operating interest expense	69.19%8.82M	118.99%1.9M	109.24%5.21M	106.01%1.23M	38.82%869K	-20.88%2.49M	-1.17%674K	-21.72%591K	-27.31%599K	-29.35%626K
Total other finance cost	-1.83%10.95M	----	699.00%11.15M	----	----	-88.08%1.4M	--0	-93.72%389K	--342K	--665K
Net investment income	384.00%7.92M	-264.91%-4.36M	-75.61%1.64M	-39.16%3.09M	120.23%2.65M	-79.83%6.71M	84.79%-681K	-77.33%1.12M	-75.88%5.07M	-89.81%1.2M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets			0			87.05%-12.99M
Income from associates and other participating interests
Special income (charges)	0	831K	-247.41%-60.61M			60.47%-17.45M
Less:Other special charges	----	----	--60.61M	----	----	----	----	----	----	----
Less:Write off	----	---831K	--0	----	----	--17.45M	----	----	----	----
Other non-operating income (expenses)	78.07%-844K	18.94%-2.79M	-499.38%-3.85M	-661.60%-952K	-2,035.40%-3.44M	92.30%-642K	-103.46%-140K	-58.82%-216K	99.05%-125K	-116.50%-161K
Income before tax	51.08%-630.49M	53.26%-149.77M	-55.87%-1.29B	-30.14%-199.45M	-216.25%-320.45M	-87.80%-826.8M	-85.63%-372.86M	-64.37%-199.36M	-66.56%-153.26M	-288.13%-101.33M
Income tax	0.00%1.6M	0.00%398K	0.00%1.6M	0.00%399K	0.00%398K	0.00%1.6M	0.00%399K	0.00%399K	0.00%399K	0.00%398K
Net income	51.01%-632.09M	53.20%-150.17M	-55.76%-1.29B	-30.06%-199.84M	-215.40%-320.85M	-87.48%-828.4M	-85.46%-373.25M	-64.16%-199.76M	-66.27%-153.66M	-283.80%-101.73M
Net income continuous operations	51.01%-632.09M	53.20%-150.17M	-55.76%-1.29B	-30.06%-199.85M	-215.40%-320.85M	-87.48%-828.4M	-85.46%-373.26M	-64.16%-199.76M	-66.28%-153.66M	-283.81%-101.73M
Noncontrolling interests			0	0	0	-31.29%-15.99M	-342.94%-4.76M	33.01%-3.82M	6.75%-3.54M	16.73%-3.87M
Net income attributable to the company	51.01%-632.09M	53.20%-150.17M	-58.82%-1.29B	-33.12%-199.84M	-227.87%-320.85M	-89.07%-812.41M	-81.33%-368.49M	-68.93%-195.94M	-69.40%-150.12M	-347.65%-97.86M
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	51.01%-632.09M	53.20%-150.17M	-58.82%-1.29B	-33.12%-199.84M	-227.87%-320.85M	-89.07%-812.41M	-81.33%-368.49M	-68.93%-195.94M	-69.40%-150.12M	-347.65%-97.86M
Gross dividend payment
Basic earnings per share	64.10%-13.19	65.87%-3.41	-43.74%-36.74	-29.68%-6.16	-218.15%-9.99	-76.28%-25.56	-69.71%-11.54	-55.58%-6.13	-57.28%-4.75	-324.32%-3.14
Diluted earnings per share	64.10%-13.19	65.87%-3.41	-43.74%-36.74	-29.68%-6.16	-218.15%-9.99	-76.28%-25.56	-69.71%-11.54	-55.58%-6.13	-57.28%-4.75	-324.32%-3.14
Dividend per share
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Middle East conflict spreads to the stock market! How should investors respond?

The negotiations between the US and Iran have entered a critical window amid external expectations and various parties' maneuvering, with th Show More

牛牛課堂

Mar 4 17:09

Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.

牛牛課堂

Mar 18 18:18

Hormuz, Term Structure and USO: Navigating the Energy Storm